Does Dr. ASHIM AGGARWAL have financial conflicts of interest?

Dr. ASHIM AGGARWAL (M.D.) has received a total of $2,756 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $2,756 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ASHIM AGGARWAL?

According to CMS Open Payments data, Dr. ASHIM AGGARWAL received funding from REGENERON HEALTHCARE SOLUTIONS ($865), ALIMERA SCIENCES ($531), and APELLIS PHARMACEUTICALS ($391).

Does Dr. ASHIM AGGARWAL receive research grants or speaking fees?

Dr. ASHIM AGGARWAL has received $2,756 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ASHIM AGGARWAL

M.D.Real-Time Hydrated

Specialty: Ophthalmology

Practice Location: EAST LANSING, MI 48823

NPI Number: 1891779286

LIFETIME INDUSTRY VALUE

$2,756

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AGGARWAL is a verified Ophthalmology practitioner based in EAST LANSING, MI.

Between 2021 and 2025, Dr. AGGARWAL had an overall industry promotional and research financial footprint of $2,756 as recorded in the federal CMS Open Payments database.

$2,756 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AGGARWAL's primary funding source is REGENERON HEALTHCARE SOLUTIONS, which accounts for $865 (representing 31.4% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

REGENERON HEALTHCARE SOLUTIONS

Rank 1

$865

31.4%

ALIMERA SCIENCES

Rank 2

$531

19.3%

APELLIS PHARMACEUTICALS

Rank 3

$391

14.2%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.